Clinical Trial Update: NAVA Versus BiPAP Non-Invasive Respiratory Support in Infants Following Congenital Heart Surgery [NA]

View source ↗

Summary

A clinical trial comparing NAVA versus BiPAP non-invasive respiratory support in infants after congenital heart surgery has been terminated with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Respiratory Failure in Infants Following Congenital Heart Surgery

Snippet

Sponsor: Children's Hospitals and Clinics of Minnesota | Conditions: Respiratory Failure | NA | Status: TERMINATED | Results posted: 2019-10-15